Copyright
©The Author(s) 2025.
World J Radiol. May 28, 2025; 17(5): 106084
Published online May 28, 2025. doi: 10.4329/wjr.v17.i5.106084
Published online May 28, 2025. doi: 10.4329/wjr.v17.i5.106084
Table 1 Summary of key imaging biomarkers for hydrocephalus assessment and their clinical applicability
Biomarker | Benefits | Applicability |
Levene’s index | Tailored for neonates (≤ 40 weeks of gestational age); correlates with gestational age. Useful for defining early intervention thresholds (e.g., > 4 mm above the 97th percentile) | Used in preterm infants via transfontanellar ultrasound. Requires population-specific nomograms |
Thalamo-occipital distance | Assesses posterior ventricular dilation. Pathological values vary by population and age (e.g., > 24 mm is considered pathological in some studies) | Measured via parasagittal ultrasound or MRI. Complements anteriorly focused indices |
Evans’ index | Simple and quick measurement; considers cranial size proportionality. Widely used in clinical practice | Applicable in MRI, CT, and transfontanellar ultrasound. Lacks standardized pediatric cut-off values |
Cella media index | Relates ventricular size to brain tissue volume. Normal values > 4; correlates with third ventricle size | Applied in MRI/CT. Useful for assessing global ventricular dilation |
Fronto-occipital horn ratio | Evaluates global ventricular dilation (includes frontal and occipital horns). The mean value in healthy individuals is approximately 0.37; a value above 0.44 indicates pathology | Validated in MRI, CT, and ultrasound. Age-independent reference ranges |
Bicaudate index | Focuses on frontal horn size; useful for assessing ventricular symmetry | Limited to MRI/CT (technical challenges in ultrasound). Less reliable in asymmetry or congenital malformations |
Anteroposterior lateral ventricle index | Measures the anteroposterior ventricular diameter relative to intracranial size. Has potential for detecting subtle pathological changes | Used in MRI/CT (axial plane reconstruction based on the AC-PC line). Not yet validated in pediatric populations, but it shows promise |
Volumetric analysis | Quantifies total CSF volume; detects progressive changes that may be missed by linear indices. Shows better correlation with functional impairment | Requires high-resolution MRI and specialized software. Limited by cost and clinical workflow constraints |
- Citation: Navarro-Ballester A, Álvaro-Ballester R, Lara-Martínez MÁ. Imaging biomarkers for detection and longitudinal monitoring of ventricular abnormalities from birth to childhood. World J Radiol 2025; 17(5): 106084
- URL: https://www.wjgnet.com/1949-8470/full/v17/i5/106084.htm
- DOI: https://dx.doi.org/10.4329/wjr.v17.i5.106084